A phase II study of patients with metastatic or locoregionally recurrent nasopharyngeal carcinoma and evaluation of plasma Epstein-Barr virus DNA as a biomarker of efficacy.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Works in Cancer Chemotherapy & Pharmacology, 2008, Vol 62, Issue 1
Results: 22
1
2
Preclinical studies of treosulfan demonstrate potent activity in Ewing's sarcoma.
- Published in:
- 2008
- By:
- Publication type:
- journal article
3
A randomized trial of anemia correction with two different hemoglobin targets in the first-line chemotherapy of advanced gastric cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 1, p. 1, doi. 10.1007/s00280-007-0561-1
- By:
- Publication type:
- Article
4
Pharmacokinetics of a HER2 tyrosine kinase inhibitor CP-724,714 in patients with advanced malignant HER2 positive solid tumors: correlations with clinical characteristics and safety.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 1, p. 97, doi. 10.1007/s00280-007-0579-4
- By:
- Publication type:
- Article
5
Phase 2B trial of aminopterin in multiagent therapy for children with newly diagnosed acute lymphoblastic leukemia.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 1, p. 65, doi. 10.1007/s00280-007-0576-7
- By:
- Publication type:
- Article
6
Efficacy of a nitrogen-containing bisphosphonate, minodronate, in conjunction with a p38 mitogen activated protein kinase inhibitor or doxorubicin against malignant bone tumor cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 1, p. 111, doi. 10.1007/s00280-007-0580-y
- By:
- Publication type:
- Article
7
Efficacy and safety of trastuzumab plus capecitabine in heavily pretreated patients with HER2-positive metastatic breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 1, p. 159, doi. 10.1007/s00280-007-0586-5
- By:
- Publication type:
- Article
8
Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 1, p. 149, doi. 10.1007/s00280-007-0585-6
- By:
- Publication type:
- Article
9
Pharmacodynamic model for chemotherapy-induced anemia in rats.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 1, p. 123, doi. 10.1007/s00280-007-0582-9
- By:
- Publication type:
- Article
10
Mechanistic study of potentiation of chemotherapy by a haloenol lactone derivative in vitro.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 1, p. 117, doi. 10.1007/s00280-007-0581-x
- By:
- Publication type:
- Article
11
Semimechanistic pharmacokinetic/pharmacodynamic model for hepatoprotective effect of dexamethasone on transient transaminitis after trabectedin (ET-743) treatment.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 1, p. 135, doi. 10.1007/s00280-007-0583-8
- By:
- Publication type:
- Article
12
Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative, for the treatment of patients with non-small cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 1, p. 173, doi. 10.1007/s00280-007-0665-7
- By:
- Publication type:
- Article
13
Bisphosphonates induce apoptosis in CLL cells independently of MDR phenotype.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 1, p. 165, doi. 10.1007/s00280-008-0710-1
- By:
- Publication type:
- Article
14
Phase I study of vinorelbine and irinotecan in previously untreated patients with advanced non-small cell lung cancer.
- Published in:
- 2008
- By:
- Publication type:
- journal article
15
Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 1, p. 33, doi. 10.1007/s00280-007-0570-0
- By:
- Publication type:
- Article
16
Sequential vinorelbine–capecitabine followed by docetaxel in advanced breast cancer: long-term results of a pilot phase II trial.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 1, p. 11, doi. 10.1007/s00280-007-0565-x
- By:
- Publication type:
- Article
17
A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 1, p. 77, doi. 10.1007/s00280-007-0577-6
- By:
- Publication type:
- Article
18
A phase II study of patients with metastatic or locoregionally recurrent nasopharyngeal carcinoma and evaluation of plasma Epstein–Barr virus DNA as a biomarker of efficacy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 1, p. 59, doi. 10.1007/s00280-007-0575-8
- By:
- Publication type:
- Article
19
Suppression of thymidine phosphorylase expression by promoter methylation in human cancer cells lacking enzyme activity.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 1, p. 85, doi. 10.1007/s00280-007-0578-5
- By:
- Publication type:
- Article
20
Preclinical studies of treosulfan demonstrate potent activity in Ewing’s sarcoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 1, p. 19, doi. 10.1007/s00280-007-0566-9
- By:
- Publication type:
- Article
21
Rapid complete remission in multiple myeloma with bortezomib/thalidomide/dexamethasone combination therapy following development of tumor lysis syndrome.
- Published in:
- 2008
- By:
- Publication type:
- Letter
22
In vitro evaluation of the effects of gefitinib on the modulation of cytotoxic activity of selected anticancer agents in a panel of human ovarian cancer cell lines.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 1, p. 51, doi. 10.1007/s00280-007-0572-y
- By:
- Publication type:
- Article